Inventor · disambiguated record

Anthony Gramolini

Also filed as: GRAMOLINI ANTHONY · GRAMOLINI ANTHONY O

5 granted patents·5 pending applications·19 citations·filing 2003–2019

76Inventor score

Technology areasG01N A01K

Files withWIENHUES-THELEN URSULA-HENRIKE4 ROCHE DIAGNOSTICS OPERATIONS2 ROCHE DIAGNOSTICS OPERATIONS INC2 UNIV DUKE1 UNIV TORONTO1

Top patents by PatentIndex Score

10 records

0192US10488422B2Use of IGFBP-7 in the assessment of heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Granted Nov 26, 2019·7 cites·17 claims
0287US10996229B2Use of IGFBP-7 in the assessment of heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2019·Granted May 4, 2021·2 cites·16 claims
0379US8691587B2Use of SFRP-3 in the assessment of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2010·Granted Apr 8, 2014·5 cites·19 claims
0462US2015293122A1Use of igfbp-7 in the assessment of heart failureROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
0560US9267954B2Use of SLIM-1 in the assessment of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2009·Granted Feb 23, 2016·1 cites·3 claims
0657US2010285491A1Use of igfbp-7 in the assessment of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2009·Application pending·0 cites
0756US2014193845A1Use of sfrp-3 in the assessment of heart failureUNIV TORONTO·Filed 2014·Application pending·0 cites
0851US7144706B2Methods of modulating localization and physiological function of IP3 receptorsUNIV DUKE·Filed 2003·Granted Dec 5, 2006·4 cites·5 claims
0937US2016146836A1Use of alpha-crystallin b (cryab) in the assessment of heart failureROCHE DIAGNOSTICS OPERATIONS·Filed 2016·Application pending·0 cites
1037US2011165591A1Use of biglycan in the assessment of heart failureWIENHUES-THELEN URSULA-HENRIKE·Filed 2011·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Anthony Gramolini files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →